Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Cancer Biology & Therapy|May 15, 2009
Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cellsRekha Rao, Pearl Lee, Warren Fiskus, et al.
Cancer Research|August 10, 2016
SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing AgentsWarren Fiskus, Veena Coothankandaswamy, Jianguang Chen, et al.
British Journal of Haematology|May 25, 2013
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosisDaniel J DeAngelo, Ruben A Mesa, Warren Fiskus, et al.
Blood|July 30, 2009
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cellsWarren Fiskus, Yongchao Wang, Arun Sreekumar, et al.
Blood|December 17, 2008
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanismJianguang Chen, Warren Fiskus, Kelly Eaton, et al.
Blood|July 2, 2011
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1Ramesh Balusu, Warren Fiskus, Rekha Rao, et al.
Leukemia|September 29, 2016
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cellsDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Molecular Pharmacology|January 27, 2006
Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib)Zhengming Chen, Francis Y Lee, Kapil N Bhalla, et al.
Blood|August 9, 2015
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinibBaohua Sun, Bhavin Shah, Warren Fiskus, et al.
Pageof 13